Large-scale testing (Phase 3)WithdrawnNCT01274221
What this trial is testing
Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Who this might be right for
ADHD
Shire
Showing 20 of 285 results